Oxycodone vs. Fentanyl in Early Postoperative Pain After Total Hip Replacement
NCT ID: NCT03019562
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
46 participants
INTERVENTIONAL
2016-12-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Analgesic Efficacy of Oxycodone Hydrochloride Versus Fentanyl After Total Hip Arthroplasty:
NCT05602519
Oxycodone Versus Intravenous Morphine for Postoperative Analgesia After Hip Surgery
NCT01536301
Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery
NCT02295124
A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Total Hip Replacement: The E-TRANS Fentanyl Transdermal System Versus the Morphine Intravenous Pump
NCT00264485
Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type
NCT01119209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxycodone
4mg of oxycodone iv bolus
Oxycodone
4mg of oxycodone iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA)
Fentanyl
50ug of fentanyl iv bolus
Fentanyl
50ug of fentanyl iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA),
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxycodone
4mg of oxycodone iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA)
Fentanyl
50ug of fentanyl iv 20 min before the end of surgery, 10ug/kg of fentanyl in Patient-Controlled Analgesia(PCA),
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status classification I or II
* Scheduled for total hip replacement surgery
Exclusion Criteria
* Patient with asthma or COPD, patient who is severely respiratory depressed
* Renal of hepatic insufficiency
* Epileptic status
* Intracranial lesion associated with increased intracranial pressure
* Acute abdomen, patient who has diagnosed paralytic ileus or suspicious ileus
* Pregnant or lactating women
19 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyunghee University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mi Kyeong Kim
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mi Kyeong Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Kyunghee University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyung Hee University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KHUH 2016-09-047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.